Powered 500 · 2026POWEREDS. 447 of 500
After co-founding 23andMe in 2006 and steering it through landmark FDA approval for direct-to-consumer health risk reports, Wojcicki built a 14-million-person genetic database that now powers pharmaceutical drug discovery at industrial scale.
Anne Wojcicki is the Co-Founder of 23andMe, the direct-to-consumer genetic testing company that made personal genomics accessible to over 14 million people worldwide.
Wojcicki co-founded 23andMe in 2006 and led it as CEO through its 2021 public listing, navigating significant FDA regulatory challenges to gain approval for direct-to-consumer health risk reports. In March 2025, 23andMe filed for Chapter 11 bankruptcy and Wojcicki stepped down as CEO; in mid-2025, TTAM Research Institute, a nonprofit she leads, acquired substantially all of the company's assets for approximately $305 million. Her creation of an entirely new consumer health category and the world's largest consumer genetic database represents a transformative contribution to personalized medicine.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
